AnaBios' Series B - II Round

AnaBios raised a round of funding on December 27, 2016. Investors include Principia SGR.

AnaBios provides human-based drug response profiles in advance of clinical trials. AnaBios' Phase X (human tissue-based ex-vivo drug development studies) enables decision making concerning compound se…

Articles about AnaBios' Series B - II Round: